Search
ocriplasmin ophthalmic (Jetrea)
Indications:
- vitreomacular traction
- macular hole
Dosage:
- 125 ug injections [1]
- single-use glass vial containing 0.5 mg ocriplasmin in 0.2 mL solution for intravitreal injection after dilution [2]
Mechanism of action:
- recombinant truncated form of human plasmin
General
ocriplasmin
ophthalmic agent (eyedrops)
References
- Stalmans P et al
Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular
Traction and Macular Holes.
N Engl J Med 2012; 367:606-615
PMID: 22894573
http://www.nejm.org/doi/full/10.1056/NEJMoa1110823
Huang J et al
N Engl J Med 2012; 367:2052-2054
http://www.nejm.org/doi/full/10.1056/NEJMc1211068
- Jetrea
http://www.rxlist.com/jetrea-drug.htm